You are here

Pfizer

Pharma’s ‘it’ therapy — a new drug class gaining steam

Pharma Voice

Wed, 09/4/24 - 11:30 am

protein degradation

Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster

Clinical Trials Arena

Tue, 09/3/24 - 11:25 am

clinical trials

After obesity, Pfizer and Flagship pick 2 more targets for multibillion-dollar partnership

Fierce Biotech

Wed, 08/28/24 - 11:33 am

Flagship Pioneering

ProFound Therapeutics

Pfizer launches new website for migraine, respiratory offerings

Reuters

Tue, 08/27/24 - 10:57 am

Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Reuters

Fri, 08/23/24 - 10:59 am

Updated COVID shots from Pfizer, Moderna cleared by FDA

BioPharma Dive

Thu, 08/22/24 - 10:03 pm

Moderna Therapeutics

Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’

Longevity Technology

Wed, 08/21/24 - 11:26 am

Ambrosia Biosciences

Array Biopharma

Pfizer, BioNTech's combo mRNA shot is latest to be defeated by influenza strain B

Fierce Biotech

Fri, 08/16/24 - 11:25 am

US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case

Fierce Pharma

Thu, 08/15/24 - 10:33 pm

Patent Infringement

Pfizer appoints AI chief, expanding digital leadership team

BioPharma Dive

Wed, 08/14/24 - 11:07 am

artificial intelligence

Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults

Fierce Pharma

Mon, 08/12/24 - 11:42 am

immunocompromised patients

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak

Fierce Biotech

Wed, 08/7/24 - 11:19 am

antibody-drug conjugate

Pfizer to create 500 new jobs as it upgrades Australia manufacturing plant to help fight antimicrobial resistance

Fierce Pharma

Tue, 08/6/24 - 05:59 pm

antimicrobial resistance

drug manufacturing

Ex-Pfizer drug reduces osteoarthritis pain in British biotech's phase 2 study

Fierce Biotech

Tue, 08/6/24 - 11:16 am

Pfizer, GSK and Moderna execs remain optimistic about RSV vaccines despite CDC blowback

Pharma Voice

Tue, 08/6/24 - 11:13 am

Moderna Therapeutics

Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations

BioSpace

Mon, 08/5/24 - 11:21 am

Ribon Therapeutics

PARP inhibitors

RSV Vaccine Makers Hit Hard by New CDC Guidelines

BioSpace

Sun, 08/4/24 - 06:35 pm

Moderna Therapeutics

Pfizer’s Bourla confident in company’s obesity drug position, despite delays

Pharma Voice

Thu, 08/1/24 - 11:14 am

Despite Late-Stage Hemophilia Win, Sangamo Remains in Do-or-Die Situation

BioSpace

Wed, 07/31/24 - 10:48 am

Sangamo BioSciences

Pages